Jonggi Choi

43PUBLICATIONS
82CO-AUTHORS
Predictive and prognostic markersPreventative health careRespiratory diseasesMolecular targetsBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|May 12, 2026
Glucagon-Like Peptide-1 Receptor Agonist Use and Liver-Related Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes in the All of Us Research Program.

|May 12, 2026
Proposal for Modified Alpha Fetoprotein Use in Hepatocellular Carcinoma Surveillance: Analysis of the 2018-2020 National Cancer Screening Program.

|Apr 14, 2026
Comparative Renal Safety of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A Korean Nationwide Study.

Jihye Lim, Jiwon Yang, Ye-Jee Kim

|Apr 13, 2026
GLP-1RA plus SGLT2i combination therapy and liver fibrosis progression in MASLD with type 2 diabetes.

Jonggi Choi, Gabby Mitchell, Vy H Nguyen

|Feb 06, 2026
Atherosclerotic Cardiovascular Risk in Patients with Chronic Hepatitis B: Tenofovir Disoproxil Fumarate Vs. Tenofovir Alafenamide: A Korean Nationwide Study.

Jiwon Yang, Jihye Lim, Ye-Jee Kim

|Dec 16, 2025
Association of Sodium-Glucose Cotransporter-2 Inhibitors With Reduced Hepatocellular Carcinoma Risk in Patients With Type 2 Diabetes.

Jonggi Choi, Vy H Nguyen, Eric Przybyszewski

Pageof 8

Frequent Collaborators

18 joint publications

Young-Suk Lim

14 joint publications

Won-Mook Choi

14 joint publications

Ju Hyun Shim

14 joint publications

Han Chu Lee